Enhancing Resilience in Senior Living Community Residents: A Randomized Controlled Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Quality of Life
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 288
- Locations
- 1
- Primary Endpoint
- Flourishing: Flourishing Measure (FM)
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
This randomized waitlist-controlled trial tests the efficacy of the Stress Management and Resiliency Training Relaxation Response Resiliency Program (SMART-3RP), a mind-body intervention, to enhance resilience and flourishing among residents in continuing care retirement communities. The investigators hypothesize that participants in the SMART-3RP group will report greater increases in resilience and flourishing relative to participants in the control group.
Detailed Description
This randomized control trial tests the efficacy of the Stress Management and Resiliency Training Relaxation Response Resiliency Program (SMART-3RP) to improve resilience and flourishing among older adults residing in continuing care retirement communities relative to a wait-list control group. At enrollment, participants will be randomly assigned to the intervention group or the control group using computer generated 1:1 blocked randomization stratified by community site. The intervention group will receive the SMART-3RP program immediately upon enrollment; the wait-list control group will be invited to receive the SMART-3RP program after the final survey time point. An estimate of 360 participants will be recruited from up to nine geographically diverse Erickson Senior Living communities.
Investigators
Lara Traeger
Assistant Professor
Massachusetts General Hospital
Eligibility Criteria
Inclusion Criteria
- •Resident of an Erickson Senior Living community
- •Currently residing in an Erickson Senior Living apartment home
- •Sufficient English language skills to participate in study procedures
Exclusion Criteria
- •Unable or unwilling to provide informed consent
- •Unable or unwilling to participate in in-person group sessions
Outcomes
Primary Outcomes
Flourishing: Flourishing Measure (FM)
Time Frame: Up to 12 weeks
We will investigate longitudinal differences in flourishing between study groups (FM score range 0-10), with higher scores indicating greater flourishing.
Resilience: Current Experiences Scale (CES)
Time Frame: Up to 12 weeks
We will investigate longitudinal differences in resilience between study groups (CES score range 0-115), with higher scores indicating greater resilience.
Secondary Outcomes
- Psychological distress: Patient Health Questionnaire 4 (PHQ4)(Up to 12 weeks)
- Community well-being: Community Well Being Survey (CWB)(Up to 12 weeks)
- Coping self-efficacy: Measure of Current Status - Part A (MOCS-A)(Up to 12 weeks)
- Positive affect: Positive and Negative Affect Schedule - Positive Subscale (PANAS-POS)(Up to 12 weeks)
- Physical symptoms: Condensed Memorial Symptom Assessment Scale (CMSAS)(Up to 12 weeks)
- Social isolation: Patient-Reported Outcomes Measurement Information System - Social Isolation (PROMIS-SI)(Up to 12 weeks)